Mesa Laboratories Inc (MLAB)

Financial leverage ratio

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Total assets	US$ in thousands	446,796	741,769	637,188	642,611	661,832	662,984	656,231	685,811	707,369	721,712	609,102	612,490	601,475	621,636	588,932	576,733	409,108	423,467	392,465	159,671
Total stockholders’ equity	US$ in thousands	145,393	402,961	387,759	387,719	393,480	387,205	374,236	380,431	393,801	396,329	399,417	399,003	406,227	412,795	392,412	382,234	220,013	235,260	230,246	119,047
Financial leverage ratio		3.07	1.84	1.64	1.66	1.68	1.71	1.75	1.80	1.80	1.82	1.52	1.54	1.48	1.51	1.50	1.51	1.86	1.80	1.70	1.34

March 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $446,796K ÷ $145,393K
= 3.07

The financial leverage ratio of Mesa Laboratories Inc has shown some fluctuations over the past few quarters. The ratio was highest at 3.07 on March 31, 2024, indicating that the company had higher financial leverage during that period. This could mean that a significant portion of Mesa Laboratories' assets were financed through debt rather than equity.

The ratio then decreased to 1.84 on December 31, 2023, before fluctuating between 1.64 and 1.82 over the next several quarters. These fluctuations suggest varying levels of debt and equity financing in the company's capital structure during these periods.

Overall, Mesa Laboratories Inc appears to have maintained moderate to high financial leverage, with the ratio generally above 1.50. It is important for investors and stakeholders to monitor the financial leverage ratio to assess the company's risk profile and financial stability.